Dengue 3d animation | cause symptoms prevention | dengue fever | dengue shock syndrome | dengue hemorrhagic fever | virus mosquito bite Hi I am Yashasvi Malik ( MBBS student at Maharaja Agrasen Medical College Agroha ). Welcome to my youtube channel. About this video Dengue viruses are spread to people through the bite of an infected Aedes species (Ae. aegypti or Ae. albopictus) mosquito. The virus responsible for causing dengue, is called dengue virus (DENV). There are four DENV serotypes and it is possible to be infected four times. SYMPTOMS Dengue fever causes a high fever — 104 F (40 C) — and any of the following signs and symptoms: Headache Muscle, bone or joint pain Nausea Vomiting Pain behind the eyes Swollen glands Rash DENGUE HEMORRHAGIC FEVER Some patients with dengue fever go on to develop dengue hemorrhagic fever (DHF), a severe and sometimes fatal form of the disease. Around the time the fever begins to subside (usually 3–7 days after symptom onset), the patient may develop warning signs of severe disease. Warning signs include severe abdominal pain, persistent vomiting, marked change in temperature (from fever to hypothermia), hemorrhagic manifestations, or change in mental status (irritability, confusion, or obtundation). The patient also may have early signs of shock, including restlessness, cold clammy skin, rapid weak pulse, and narrowing of the pulse pressure (systolic blood pressure − diastolic blood pressure). Patients with dengue fever should be told to ret DENGUE SHOCK SYNDROME Signs of dengue shock syndrome: Abdominal pain or tenderness Persistent vomiting Lethargy or restlessness Liver enlargement Increases in hematocrit concurrent with rapid decrease in platelet count Shock syndrome will occur after 2 to 7 days of infection, patients can be seen getting affected with symptoms like, blueness around the mouth, spitting up of blood, heart inflammation, pneumonia, sudden collapse, weak pulse, easy bruising and bleeding are some of the major symptoms. VACCINE A new dengue vaccine is approved for use in children aged 9–16 years with laboratory-confirmed previous dengue virus infection and living in areas where dengue is endemic (occurs frequently or continuously). Endemic areas include some U.S. territories and freely associated states. The vaccine is not approved for use in U.S. travelers who are visiting but not living in an area where dengue is common. #dengue #denguefever #denguemosquito #denguevirus #dengueprevention #dengueawareness #denguefeversymptoms #denguesymptoms